Epidemiology of bronchopulmonary dysplasia

Birth Defects Research Part A - Clinical and Molecular Teratology

Volumn 100, Issue 3, 2014, Pages 145-157

  Jensen, Erik A ^a   Schmidt, Barbara ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

Bronchopulmonary dysplasia; Chronic lung disease; Epidemiology; Mechanical ventilation; Very low birth weight

Indexed keywords

ADVERSE OUTCOME; ARTICLE; ARTIFICIAL VENTILATION; BIRTH WEIGHT; CHRONIC RESPIRATORY TRACT DISEASE; DEVELOPMENTAL DISORDER; DISEASE ASSOCIATION; GESTATIONAL AGE; HUMAN; INCIDENCE; INTRAUTERINE GROWTH RETARDATION; LUNG DYSPLASIA; NONHUMAN; OXYGEN THERAPY; PREMATURE LABOR; PRIORITY JOURNAL; RISK FACTOR; SEPSIS; BRONCHOPULMONARY DYSPLASIA; FEMALE; LOW BIRTH WEIGHT; MALE; NEWBORN; PREMATURITY;

BRONCHOPULMONARY DYSPLASIA; FEMALE; HUMANS; INCIDENCE; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; INFANT, PREMATURE; MALE; RISK FACTORS;

EID: 84896489835     PISSN: 15420752     EISSN: 15420760     Source Type: Journal    
DOI: 10.1002/bdra.23235     Document Type: Article

References (166)

1. ACOG Committee Opinion No. 475. 2011. Antenatal corticosteroid therapy for fetal maturation. Obstet Gynecol 117:422-424.
2. Akinola E, Rosenkrantz TS, Pappagallo M, et al. 2004. Gastroesophageal reflux in infants<32 weeks gestational age at birth: lack of relationship to chronic lung disease. Am J Perinatol 21:57-62.
3. Ambalavanan N, Van Meurs KP, Perritt R, et al. 2008. Predictors of death or bronchopulmonary dysplasia in preterm infants with respiratory failure. J Perinatol 28:420-426.
4. An HS, Bae EJ, Kim GB, et al. 2010. Pulmonary hypertension in preterm infants with bronchopulmonary dysplasia. Korean Circ J 40:131-136.
5. Andrews WW, Goldenberg RL, Faye-Petersen O, et al. 2006. The Alabama Preterm Birth study: polymorphonuclear and mononuclear cell placental infiltrations, other markers of inflammation, and outcomes in 23- to 32-week preterm newborn infants. Am J Obstet Gynecol 195:803-808.
6. Antonucci R, Contu P, Porcella A, et al. 2004. Intrauterine smoke exposure: a new risk factor for bronchopulmonary dysplasia? J Perinat Med 32:272-277.
7. Askie LM, Henderson-Smart DJ, Irwig L, Simpson JM. 2003. Oxygen-saturation targets and outcomes in extremely preterm infants. N Engl J Med 349:959-967.
8. Avery ME, Tooley WH, Keller JB, et al. 1987. Is chronic lung disease in low birth weight infants preventable? A survey of eight centers. Pediatrics 79:26-30.
9. Bancalari E, Claure N, Sosenko IRS. 2003. Bronchopulmonary dysplasia: changes in pathogenesis, epidemiology and definition. Semin Neonatol 8:63-71.
10. Bauer ML, Lyrene RK. 1999. Chronic aspiration in children: evaluation of the lipid-laden macrophage index. Pediatr Pulmonol 28:94-100.
11. Benitz WE. 2010. Treatment of persistent patent ductus arteriosus in preterm infants: time to accept the null hypothesis? J Perinatol 30:241-252.
12. Benitz WE. 2012. Patent ductus arteriosus: to treat or not to treat? Arch Dis Child Fetal Neonatal Ed 97:F80-F82.
13. Berkelhamer SK, Mestan KK, Steinhorn RH. 2013. Pulmonary hypertension in bronchopulmonary dysplasia. Semin Perinatol 37:124-131.
14. Bhat R, Salas AA, Foster C, et al. 2012. Prospective analysis of pulmonary hypertension in extremely low birth weight infants. Pediatrics 129:e682-689.
15. Bjorklund LJ, Ingimarsson J, Curstedt T. 1997. Manual ventilation with a few large breaths at birth compromises the therapeutic effect of subsequent surfactant replacement in immature lungs. Pediatr Res 42:348-355.
16. Blayney M, Kerem E, Whyte H, O'Brodovich H. 1991. Bronchopulmonary dysplasia: improvement in lung function between 7 and 10 years of age. J Pediatr 118:201-206.
17. Bolton CE, Stocks J, Hennessy E, et al. 2012. The EPICure Study: association between hemodynamics and lung function at 11 years after extremely preterm birth. J Pediatr 161:595-601.
18. Bonikos DS, Benson KG, Northway WHJ. 1976. Oxygen toxicity in the newborn. The effect of chronic continuous 100 percent oxygen exposure on the lung of newborn mice. Am J Pathol 85:623-650.
19. Bose CL, Dammann CEL, Laughon MM. 2008. Bronchopulmonary dysplasia and inflammatory biomarkers in the premature neonate. Arch Dis Child Fetal Neonatal Ed 93:F455-F461.
20. Bose C, Van Marter LJ, Laughon M, et al. 2009. Fetal growth restriction and chronic lung disease among infants born before the 28th week of gestation. Pediatrics 124:e450-458.
21. Botet F, Figueras-Aloy J, Miracle-Echegoyen X, et al. 2012. Trends in survival among extremely-low-birth-weight infants (less than 1000 g) without significant bronchopulmonary dysplasia. BMC Pediatr 12:63-70.
22. Bott L, Beghin L, Devos P, et al. 2006. Nutritional status at 2 years in former infants with bronchopulmonary dysplasia influences nutrition and pulmonary outcomes during childhood. Pediatr Res 60:340-344.
23. Carlo WA, McDonald SA, Fanaroff AA, et al. 2011. Association of antenatal corticosteroids with mortality and neurodevelopmental outcomes among infants born at 22 to 25 weeks' gestation. JAMA 306:2348-2358.
24. Carraro S, Filippone M, Da Dalt L, et al. 2013. Bronchopulmonary dysplasia: the earliest and perhaps the longest lasting obstructive lung disease in humans. Early Hum Dev 89:S3-S5.
25. Cassady G, Crouse DT, Kirklin JW, et al. 1989. A randomized, controlled trial of very early prophylactic ligation of the ductus arteriosus in babies who weighed 1000 g or less at birth. N Engl J Med 320:1511-1516.
26. Chan K, Ohlsson A, Synnes A, et al. 2001. Survival, morbidity, and resource use of infants of 25 weeks' gestational age or less. Am J Obstet Gynecol 185:220-226.
27. Check J, Gotteiner N, Liu X, et al. 2013. Fetal growth restriction and pulmonary hypertension in premature infants with bronchopulmonary dysplasia. J Perinatol 33:553-557.
28. Choi CW, Kim BI, Kim E-K, et al. 2012. Incidence of bronchopulmonary dysplasia in Korea. J Korean Med Sci 27:914.
29. Chye JK, Gray PH. 1995. Rehospitalization and growth of infants with bronchopulmonary dysplasia: a matched control study. J Paediatr Child Health 31:105-111.
30. Clyman R, Cassady G, Kirklin JK, et al. 2009. The role of patent ductus arteriosus ligation in bronchopulmonary dysplasia: reexamining a randomized controlled trial. J Pediatr 154:873-876.
31. Cooke L, Steer P, Woodgate P. 2003. Indomethacin for asymptomatic patent ductus arteriosus in preterm infants. Cochrane Database Syst Rev 1:CD003745.
32. Cornell TT, Wynn J, Shanley TP, et al. 2010. Mechanisms and regulation of the gene-expression response to sepsis. Pediatrics 125:1248-1258.
33. Costeloe KL, Hennessy EM, Haider S, et al. 2012. Short term outcomes after extreme preterm birth in England: comparison of two birth cohorts in 1995 and 2006 (the EPICure studies). BMJ 345:e7976.
34. Cotten MC, Oh W, McDonald S, et al. 2005. Prolonged hospital stay for extremely premature infants: risk factors, center differences, and the impact of mortality on selecting a best-performing center. J Perinatol 25:650-655.
35. Cotton RB, Stahlman MT, Bender HW, et al. 1978. Randomized trial of early closure of symptomatic patent ductus arteriosus in small preterm infants. J Pediatr 93:647-651.
36. Cristea AI, Carroll AE, Davis SD, et al. 2013. Outcomes of children with severe bronchopulmonary dysplasia who were ventilator dependent at home. Pediatrics 132:e727-734.
37. Darlow BA, Horwood LJ. 1992. Chronic lung disease in very low birth weight infants: a prospective population-based study. J Paediatr Child Health 28:301-305.
38. Delacourt C, d'Ortho MP, Macquin-Mavier I, et al. 1996. Oxidant-antioxidant balance in alveolar macrophages from newborn rats. Eur Respir J 9:2517-2524.
39. Delaney-Black V, Lubchenco L, Butterfield L, et al. 1989. Outcome of very-low-birth-weight infants: are populations of neonates inherently different after antenatal versus neonatal referral? Am J Obstet Gynecol 160:545-552.
40. DeMauro SB, Roberts RS, Davis P, et al. 2011. Impact of delivery room resuscitation on outcomes up to 18 months in very low birth weight infants. J Pediatr 159:546-550.
41. Doyle LW, Faber B, Callanan C, et al. 2006. Bronchopulmonary dysplasia in very low birth weight subjects and lung function in late adolescence. Pediatrics 118:108-113.
42. Dreyfuss D, Saumon G. 1998. Ventilator-induced lung injury: lessons from experimental studies. Am J Respir Crit Care Med 157:294-323.
43. Drysdale SB, Wilson T, Alcazar M, et al. 2011. Lung function prior to viral lower respiratory tract infections in prematurely born infants. Thorax 66:468-473.
44. Dunn MS, Kaempf J, de Klerk A, et al. 2011. Randomized trial comparing 3 approaches to the initial respiratory management of preterm neonates. Pediatrics 128:e1069-1076.
45. Ehrenkranz RA, Walsh MC, Vohr BR, et al. 2005. Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia. Pediatrics 116:1353-1360.
46. Ellsbury DL, Acarregui MJ, McGuinness GA, Klein JM. 2002. Variability in the use of supplemental oxygen for bronchopulmonary dysplasia. J Pediatr 140:247-249.
47. Fanaroff A, Stoll B, Wright L, et al. 2007. Trends in neonatal morbidity and mortality for very low birthweight infants. Am J Obstet Gynecol 196:147.e141-e147.
48. Farhath S, He Z, Nakhla T, Saslow J, et al. 2008. Pepsin, a marker of gastric contents, is increased in tracheal aspirates from preterm infants who develop bronchopulmonary dysplasia. Pediatrics 121:e253-e259.
49. Fawke J, Lum S, Kirkby J, et al. 2010. Lung function and respiratory symptoms at 11 years in children born extremely preterm. Am J Respir Crit Care Med 182:237-245.
50. Filbrun AG, Popova AP, Linn MJ, et al. 2011. Longitudinal measures of lung function in infants with bronchopulmonary dysplasia. Pediatr Pulmonol 46:369-375.
51. Filippone M, Bonetto G, Cherubin E, et al. 2009. Childhood course of lung function in survivors of bronchopulmonary dysplasia. JAMA 302:1418-1420.
52. Finer N, Carlo W, Walsh M, et al. 2010. Early CPAP versus surfactant in extremely preterm infants. N Engl J Med 362:1970-1979.
53. Fowlie PW, Davis PG, McGuire W. 2010. Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants. Cochrane Database Syst Rev 7:CD000174.
54. Fuloria M, Hiatt D, Dillard RG, O'Shea TM. 2000. Gastroesophageal reflux in very low birth weight infants: association with chronic lung disease and outcomes through 1 year of age. J Perinatol 20:235-239.
55. Goldenberg RL, Andrews WW, Goepfert AR, et al. 2008. The Alabama preterm birth study: umbilical cord blood Ureaplasma urealyticum and Mycoplasma hominis cultures in very preterm newborn infants. Am J Obstet Gynecol 198:43.e41-e43.
56. Gough A, Spence D, Linden M, et al. 2012. General and respiratory health outcomes in adult survivors of bronchopulmonary dysplasia. Chest 141:1554-1567.
57. Greenough A, Cox S, Alexander J, et al. 2001. Health care utilisation of infants with chronic lung disease, related to hospitalisation for RSV infection. Arch Dis Child 85:463-468.
58. Greenough A, Alexander J, Burgess S, et al. 2002. Home oxygen status and rehospitalisation and primary care requirements of infants with chronic lung disease. Arch Dis Child 86:40-43.
59. Greenough A, Alexander J, Burgess S, et al. 2006. Preschool healthcare utilisation related to home oxygen status. Arch Dis Child Fetal Neonatal Ed 91:F337-F341.
60. Hack M, Wilson-Costello D, Friedman H, et al. 2000. Neurodevelopment and predictors of outcomes of children with birth weights of less than 1000 g: 1992-1995. Arch Pediatr Adolesc Med 154:725-731.
61. Hacking DF, Gibson A-M, Robertson C, et al. 2012. Respiratory function at age 8-9 after extremely low birthweight or preterm birth in Victoria in 1997. Pediatr Pulmonol 48:449-455.
62. Hakulinen A, Heinonen K, Jokela V, Kiekara O. 1988. Occurrence, predictive factors and associated morbidity of bronchopulmonary dysplasia in a preterm birth cohort. J Perinat Med 16:437-446.
63. Halliday HL, Ehrenkranz RA, Doyle LW. 2003a. Early postnatal (< 96 hours) corticosteroids for preventing chronic lung disease in preterm infants. Cochrane Database Syst Rev 1:CD001146.
64. Halliday HL, Ehrenkranz RA, Doyle LW. 2003b. Moderately early (7-14 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants. Cochrane Database Syst Rev 1:CD001144.
65. Halliday HL, Ehrenkranz RA, Doyle LW. 2003c. Delayed (> 3 weeks) postnatal corticosteroids for chronic lung disease in preterm infants. Cochrane Database Syst Rev 1:CD001145.
66. Halliday H, Ehrenkranz R, Doyle L. 2010. Early (< 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants. Cochrane Database Syst Rev 1:CD001146.
67. Hartling L, Liang Y, Lacaze-Masmonteil T. 2011. Chorioamnionitis as a risk factor for bronchopulmonary dysplasia: a systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed 97:F8-F17.
68. Hennessy EM, Bracewell MA, Wood N, et al. 2008. Respiratory health in pre-school and school age children following extremely preterm birth. Arch Dis Child 93:1037-1043.
69. Hohlagschwandtner M, Husslein P, Klebermass K, et al. 2001. Perinatal mortality and morbidity. Comparison between maternal transport, neonatal transport and inpatient antenatal treatment. Arch Gynecol Obstet 265:113-118.
70. Horbar JD, Carpenter JH, Badger GJ, et al. 2012. Mortality and neonatal morbidity among infants 501 to 1500 grams from 2000 to 2009. Pediatrics 129:1019-1026.
71. Hughes CA, O'Gorman LA, Shyr Y, et al. 1999. Cognitive performance at school age of very low birth weight infants with bronchopulmonary dysplasia. J Dev Behav Pediatr 20:1-8.
72. Hussain AN, Siddiqui NH, Stocker JT. 1998. Pathology of arrested acinar development in postsurfactant bronchopulmonary dysplasia. Hum Pathol 29:710-717.
73. Isayama T, Lee SK, Mori R, et al. 2012. Comparison of mortality and morbidity of very low birth weight infants between Canada and Japan. Pediatrics 130:e957-e965.
74. Jadcherla SR, Peng J, Chan CY, et al. 2011. Significance of gastroesophageal fefluxate in relation to physical, chemical, and spatiotemporal characteristics in symptomatic intensive care unit neonates. Pediatr Res 70:192-198.
75. Jobe AJ. 1999. The new BPD: an arrest of lung development. Pediatr Res 46:641-643.
76. Jobe AH, Bancalari E. 2001. Bronchopulmonary dysplasia. Am J Respir Crit Care Med 163:1723-1729.
77. Jobe AH. 2012. Effects of chorioamnionitis on the fetal lung. Clin Perinatol 39:441-457.
78. Kao LC, Durand DJ, McCrea RC, et al. 1994. Randomized trial of long-term diuretic therapy for infants with oxygen-dependent bronchopulmonary dysplasia. J Pediatr 124:772-781.
79. Kapadia VS, Chalak LF, Sparks JE, et al. 2013. Resuscitation of preterm neonates with limited versus high oxygen strategy. Pediatrics 132:e1488-1496.
80. Kattwinkel J, Perlman JM, Aziz K, et al. 2010. Neonatal resuscitation: 2010 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Pediatrics 126:e1400-e1413.
81. Khemani E, McElhinney DB, Rhein L, et al. 2007. Pulmonary artery hypertension in formerly premature infants with bronchopulmonary dysplasia: clinical features and outcomes in the surfactant era. Pediatrics 120:1260-1269.
82. Kim D-H, Kim H-S, Choi CW, et al. 2012. Risk factors for pulmonary artery hypertension in preterm infants with moderate or severe bronchopulmonary dysplasia. Neonatology 101:40-46.
83. Klinger G, Levy I, Sirota L, et al. 2010. Outcome of early-onset sepsis in a national cohort of very low birth weight infants. Pediatrics 125:e736-e740.
84. Klinger G, Sokolover N, Boyko V, et al. 2013. Perinatal risk factors for bronchopulmonary dysplasia in a national cohort of very-low-birthweight infants. Am J Obstet Gynecol 208:115.e111-e115.
85. Korhonen P. Hyodynmaa E, Lenko H-L, Tammela O. 2004. Growth and adrenal androgen status at 7 years in very low birth weight survivors with and without bronchopulmonary dysplasia. Arch Dis Child 89:320-324.
86. Kraybill EN, Runyan DK, Bose CL. 1989. Risk factors for chronic lung disease in infants with birth weights of 751 to 1000 grams. J Pediatr 115:115-120.
87. Lahra MM, Beeby PJ, Jeffery HE. 2009. Intrauterine inflammation, neonatal sepsis, and chronic lung disease: a 13-year hospital cohort study. Pediatrics 123:1314-1319.
88. Lasswell SM, Barfield WD, Rochat RW, Blackmon L. 2010. Perinatal regionalization for very low-birth-weight and very preterm infants. JAMA 304:992-1000.
89. Laughon M, Allred EN, Bose C, et al. 2009. Patterns of respiratory disease during the first 2 postnatal weeks in extremely premature infants. Pediatrics 123:1124-1131.
90. Lavoie PM, Pham C, Jang KL. 2010. Genetics of bronchopulmonary dysplasia in the age of genomics. Curr Opin Pediatr 22:479-485.
91. Lee S, Ye X, Singhal N, D et al. 2013. Higher altitude and risk of bronchopulmonary ysplasia among preterm infants. Am J Perinatol 30:601-606.
92. Lopez-Alonso M, Moya MJ, Cabo JA, et al. 2006. Twenty-four-hour esophageal impedance-pH monitoring in healthy preterm neonates: rate and characteristics of acid, weakly acidic, and weakly alkaline gastroesophageal reflux. Pediatrics 118:e299-e308.
93. Lorch SA, Baiocchi M, Ahlberg CE, Small DS. 2012. The differential impact of delivery hospital on the outcomes of premature infants. Pediatrics 130:270-278.
94. Majnemer A, Riley P, Shevell M, et al. 2000. Severe bronchopulmonary dysplasia increases risk for later neurological and motor sequelae in preterm survivors. Dev Med Child Neurol 42:53-60.
95. Malviya MN, Ohlsson A, Shah SS. 2013. Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infants. Cochrane Database Syst Rev 3:CD003951.
96. Marshall DD, Kotelchuck M, Young TE, et al. 1999. Risk factors for chronic lung disease in the surfactant era: a North Carolina population-based study of very low birth weight Infants. Pediatrics 104:1345-1350.
97. Martin JA, Hamilton BE, Ventura SJ, et al. 2013. Births: final data for 2011. Natl Vital Stat Rep 62:1-69.
98. Mokres LM, Parai K, Hilgenforff A. 2010. Prolonged mechanical ventilation with air induces apoptosis and causes failure of alveolar septation and angiogenesis in lungs of newborn mice. Am J Physiol 298:L23-L35.
99. Morley CJ, Davis PG, Doyle LW, et al. 2008. Nasal CPAP or intubation at birth for very preterm infants. N Engl J Med 358:700-708.
100. Mourani PM, Sontag MK, Younoszai A, et al. 2008. Clinical utility of echocardiography for the diagnosis and management of pulmonary vascular disease in young children with chronic lung disease. Pediatrics 121:317-325.
101. Natarajan G, Pappas A, Shankaran S, et al. 2012. Outcomes of extremely low birth weight infants with bronchopulmonary dysplasia: impact of the physiologic definition. Early Hum Dev 88:509-515.
102. Natarajan G, Johnson Y, Brozanski B, et al. 2013. Postnatal weight gain in preterm infants with severe bronchopulmonary dysplasia. Am J Perinatol [Epub ahead of print].
103. Nickerson BG, Taussig LM. 1980. Family history of asthma in infants with bronchopulmonary dysplasia. Pediatrics 65:1140-1144.
104. Northway W, Rosan R, Porter D. 1967. Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. N Engl J Med 276:357-368.
105. Oh W, Poindexter BB, Perritt R, et al. 2005. Association between fluid intake and weight loss during the first ten days of life and risk of bronchopulmonary dysplasia in extremely low birth weight infants. J Pediatr 147:786-790.
106. Ohlsson A, Walia R, Shah SS. 2013. Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database Syst Rev 4:CD003481.
107. Onland W, Offringa M, van Kaam A. 2012. Late (≥7 days) inhalation corticosteroids to reduce bronchopulmonary dysplasia in preterm infants. Cochrane Database Syst Rev 4:CD002311.
108. Palmer KG, Kronsberg SS, Barton BA, et al. 2004. Effect of inborn versus outborn delivery on clinical outcomes in ventilated preterm neonates: secondary results from the NEOPAIN trial. J Perinatol 25:270-275.
109. Palta M, Gabbert D, Weinstein MR, Peters ME. 1991. Multivariate assessment of traditional risk factors for chronic lung disease in very low birth weight neonates. The Newborn Lung Project. J Pediatr 119:285-292.
110. Palta M, Sadek-Badawi M, Evans M, et al. 2000. Functional assessment of a multicenter very low-birth-weight cohort at age 5 years. Arch Pediatr Adolesc Med 154:23-30.
111. Parker RA, Lindstrom DP, Cotton RB. 1992. Improved survival accounts for most, but not all, of the increase in bronchopulmonary dysplasia. Pediatrics 90:663-668.
112. Payne NR, LaCorte M, Karna P, et al. 2006a. Reduction of bronchopulmonary dysplasia after participation in the breathsavers group of the Vermont Oxford Network neonatal intensive care quality improvement collaborative. Pediatrics 118:S73-S77.
113. Payne NR, LaCorte M, Sun S, et al. 2006b. Evaluation and development of potentially better practices to reduce bronchopulmonary dysplasia in very low birth weight infants. Pediatrics 118:S65-S72.
114. Phibbs CS, Baker LC, Caughey AB, et al. 2007. Level and volume of neonatal intensive care and mortality in very-low-birth-weight infants. N Engl J Med 356:2165-2175.
115. Rabi Y, Singhal N, Nettel-Aguirre A. 2011. Room-air versus oxygen administration for resuscitation of preterm infants: the ROAR study. Pediatrics 128:e374-381.
116. Redline RW, Faye-Petersen O, Heller D, et al. 2003. Amniotic infection syndrome: nosology and reproducibility of placental reaction patterns. Pediatr Dev Pathol 6:435-448.
117. Report of Workshop on Bronchopulmonary Dysplasia. 1979. NIH Publication No. 80-1660. Washington, DC: National Institutes of Health.
118. Roberts D, Dalziel S. 2006. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 3:CD004454.
119. Rojas MA, Gonzalez A, Bancalari E, et al. 1995. Changing trends in the epidemiology and pathogenesis of neonatal chronic lung disease. J Pediatr 126:605-610.
120. Rojas MX, Rojas MA, Lozano JM, et al. 2012. Regional variation on rates of bronchopulmonary dysplasia and associated risk factors. ISRN Pediatr 2012:1-9.
121. Salvatore S, Hauser B, Vandenplas Y. 2007. The natural course of gastro-oesophageal reflux. Acta Paediatr 93:1063-1069.
122. Sandri F, Plavka R, Ancora G, et al. 2010. Prophylactic or early selective surfactant combined with nCPAP in very preterm infants. Pediatrics 125:e1402-e1409.
123. Saugstad OD. 1998. Chronic lung disease: the role of oxidative stress. Biol Neonate 74:21-28.
124. Schlapbach LJ, Adams M, Proietti E, et al. 2012. Outcome at two years of age in a Swiss national cohort of extremely preterm infants born between 2000 and 2008. BMC Pediatr 12:198-210.
125. Schlapbach LJ, Aebischer M, Adams M, et al. 2011. Impact of sepsis on neurodevelopmental outcome in a Swiss national cohort of extremely premature infants. Pediatrics 128:e348-e357.
126. Schmidt B, Davis P, Moddemann D, et al. 2001. Long-term effects of indomethacin prophylaxis in extremely-low-birth-weight infants. N Engl J Med 344:1966-1972.
127. Schmidt B, Asztalos EV, Roberts RS, et al. 2003. Impact of bronchopulmonary dysplasia, brain injury, and severe retinopathy on the outcome of extremely low-birth-weight infants at 18 months. JAMA 289:1124-1129.
128. Schmidt B, Roberts RS, Fanaroff A, et al. 2006. Indomethacin prophylaxis, patent ductus arteriosus, and the risk of bronchopulmonary dysplasia: further analyses from the Trial of Indomethacin Prophylaxis in Preterms (TIPP). J Pediatr 148:730-734.
129. Schmidt B, Whyte RK, Asztalos EV, et al. 2013. Effects of targeting higher vs lower arterial oxygen saturations on death or disability in extremely preterm infants a randomized clinical trial. JAMA 309:2111-2120.
130. Schmolzer GM, Kumar M, Pichler G, et al. 2013. Non-invasive versus invasive respiratory support in preterm infants at birth: systematic review and meta-analysis. BMJ 347:f5980.
131. Shennan AT, Dunn MS, Ohlsson A, et al. 1988. Abnormal pulmonary outcomes in premature infants: prediction from oxygen requirement in the neonatal period. Pediatrics 82:527-532.
132. Shepard F, Gray J, Stahlman MT. 1964. Occurrence of pulmonary fibrosis in children who had idiopathic RDS. J Pediatr 65:1078.
133. Shlossman PA, Manley JS, Sciscione AC, Colmorgen GH. 1997. An analysis of neonatal morbidity and mortality in maternal (in utero) and neonatal transports at 24-34 weeks' gestation. Am J Perinatol 14:449-456.
134. Short EJ, Klein NK, Lewis BA, et al. 2003. Cognitive and academic consequences of bronchopulmonary dysplasia and very low birth weight: 8-year-old outcomes. Pediatrics 112:e359-e359.
135. Singer L, Yamashita T, Lilien L, et al. 1997. A longitudinal study of developmental outcome of infants with bronchopulmonary dysplasia and very low birth weight. Pediatrics 100:987-993.
136. Skidmore MD, Rivers A, Hack M. 1990. Increased risk of cerebral palsy among very low-birthweight infants with chronic lung disease. Dev Med Child Neurol 32:325-332.
137. Slaughter JL, Pakrashi T, Jones DE, et al. 2011. Echocardiographic detection of pulmonary hypertension in extremely low birth weight infants with bronchopulmonary dysplasia requiring prolonged positive pressure ventilation. J Perinatol 31:635-640.
138. Smith VC, Zupancic JAF, McCormick MC, et al. 2004. Rehospitalization in the first year of life among infants with bronchopulmonary dysplasia. J Pediatr 144:799-803.
139. Smith VC, Zupancic JAF, McCormick MC, et al. 2005. Trends in severe bronchopulmonary dysplasia rates between 1994 and 2002. J Pediatr 146:469-473.
140. Somaschini M, Castiglioni E, Volonteri C, et al. 2012. Genetic predisposing factors to bronchopulmonary dysplasia: preliminary data from a multicentre study. J Matern Fetal Neonatal Med 25:119-122.
141. Stoll BJ, Hansen NI, Bell EF, et al. 2010. Neonatal outcomes of extremely preterm infants from the NICHD neonatal research network. Pediatrics 126:443-456.
142. Stroustrup A, Trasande L. 2010. Epidemiological characteristics and resource use in neonates with bronchopulmonary dysplasia: 1993-2006. Pediatrics 126:291-297.
143. SUPPORT Study Group of the Eunice Kennedy Shriver NICHD Neonatal Research Network. 2010. Target ranges of oxygen saturation in extremely preterm infants. N Engl J Med 362:1959-1969.
144. te Pas AB, Walther FJ. 2007. A randomized, controlled trial of delivery-room respiratory management in very preterm infants. Pediatrics 120:322-329.
145. The BOOST II United Kingdom, Australia, and New Zealand Collaborative Groups. 2013. Oxygen Saturation and Outcomes in Preterm Infants. N Engl J Med 368:2094-2104.
146. Trzaski J, Hagadorn J, Hussain N, et al. 2011. Predictors of successful discontinuation of supplemental oxygen in very low-birth-weight infants with bronchopulmonary dysplasia approaching neonatal intensive care unit discharge. Am J Perinatol 29:79-86.
147. Tyson JE, Wright LL, Oh W, et al. 1999. Vitamin A supplementation for extremely-low-birth-weight infants. N Engl J Med 340:1962-1968.
148. Van Marter LJ, Leviton A, Allred EN, Pagano M, Kuban KC. 1990. Hydration during the first days of life and the risk of bronchopulmonary dysplasia in low birth weight infants. J Pediatr 116:942-949.
149. Van Marter LJ, Allred EN, Pagano M, et al. 2000. Do clinical markers of barotrauma and oxygen toxicity explain interhospital variation in rates of chronic lung disease? Pediatrics 105:1194-1201.
150. Van Marter LJ, Allred EN, Leviton A, et al. 2001. Antenatal glucocorticoid treatment does not reduce chronic lung disease among surviving preterm infants. J Pediatr 138:198-204.
151. Van Marter LJ, Dammann O, Allred EN, et al. 2002. Chorioamnionitis, mechanical ventilation, and postnatal sepsis as modulators of chronic lung disease in preterm infants. J Pediatr 140:171-176.
152. Vento M, Moro M, Escrig R, et al. 2009. Preterm resuscitation with low oxygen causes less oxidative stress, inflammation, and chronic lung disease. Pediatrics 124:e439-449.
153. Vermont Oxford Network. 2012. VON days pulse oximetry audit summary. Available at: http://www.vtoxford.org/quality/vondays/PO/POResultsSummary.pdf. Accessed December 17, 2013.
154. Vohr BR, Coll CG, Lobato D, et al. 1991. Neurodevelopmental and medical status of low-birthweight survivors of bronchopulmonary dysplasia at 10 to 12 years of age. Dev Med Child Neurol 33:690-697.
155. Vollsæter M, Roksund OD, Eide GE, et al. 2013. Lung function after preterm birth: development from mid-childhood to adulthood. Thorax 68:767-776.
156. Vrijlandt EJ, Gerritsen J, Boezen HM, Duiverman EJ. 2005. Gender differences in respiratory symptoms in 19-year-old adults born preterm. Respir Res 6:117.
157. Walsh MC, Wilson-Costello D, Zadell A, et al. 2003. Safety, reliability, and validity of a physiologic definition of bronchopulmonary dysplasia. J Perinatol 23:451-456.
158. Walsh MC, Yao Q, Gettner P, et al. 2004. Impact of a physiologic definition on bronchopulmonary dysplasia rates. Pediatrics 114:1305-1311.
159. Walsh MC, Morris BH, Wrage LA, et al. 2005. Extremely low birthweight neonates with protracted ventilation: mortality and 18-month neurodevelopmental outcomes. J Pediatr 146:798-804.
160. Walsh M, Laptook A, Kazzi SN, et al. 2007. A cluster-randomized trial of benchmarking and multimodal quality improvement to improve rates of survival free of bronchopulmonary dysplasia for infants with birth weights of less than 1250 grams. Pediatrics 119:876-890.
161. Walter EC, Ehlenbach WJ, Hotchkin DL, et al. 2009. Low birth weight and respiratory disease in adulthood. Am J Respir Crit Care Med 180:176-180.
162. Warner B, Musial MJ, Chenier T, Donovan E. 2004. The effect of birth hospital type on the outcome of very low birth weight infants. Pediatrics 113:35-41.
163. Werthammer J, Brown ER, Neff RK, Taeusch HW Jr. Sudden infant death syndrome in infants with bronchopulmonary dysplasia. Pediatrics 69:301-304.
164. Wood NS, Costeloe K, Gibson AT, et al. 2005. The EPICure study: associations and antecedents of neurological and developmental disability at 30 months of age following extremely preterm birth. Arch Dis Child Fetal Neonatal Ed 90:F134-F140.
165. Wynn J, Cornell TT, Wong HR, et al. 2010. The host response to sepsis and developmental impact. Pediatrics 125:1031-1041.
166. Zeitlin J, Draper ES, Kollee L, et al. 2008. Differences in rates and short-term outcome of live births before 32 weeks of gestation in Europe in 2003: results from the MOSAIC Cohort. Pediatrics 121:e936-944.